Urovant Sciences
Founded in 2016, Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. The company is headquartered in London, United Kingdom.
Last updated on
About Urovant Sciences
Founded
2017Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$300MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
IrvineState
CaliforniaCountry
United StatesUrovant Sciences
Find your buyer within Urovant Sciences